310 related articles for article (PubMed ID: 22374786)
1. Frequent activating GNAS mutations in villous adenoma of the colorectum.
Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
[TBL] [Abstract][Full Text] [Related]
2. Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.
Sekine S; Ogawa R; Oshiro T; Kanemitsu Y; Taniguchi H; Kushima R; Kanai Y
Genes Chromosomes Cancer; 2014 Apr; 53(4):366-72. PubMed ID: 24470207
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
[TBL] [Abstract][Full Text] [Related]
4. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.
Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ
Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
Kakar S; Deng G; Cun L; Sahai V; Kim YS
Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
[TBL] [Abstract][Full Text] [Related]
6. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
7. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
[TBL] [Abstract][Full Text] [Related]
9. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
[TBL] [Abstract][Full Text] [Related]
10. Tracing origin of serrated adenomas with BRAF and KRAS mutations.
Lee EJ; Choi C; Park CK; Maeng L; Lee J; Lee A; Kim KM
Virchows Arch; 2005 Sep; 447(3):597-602. PubMed ID: 15991007
[TBL] [Abstract][Full Text] [Related]
11. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
12. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
[TBL] [Abstract][Full Text] [Related]
13. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S
Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268
[TBL] [Abstract][Full Text] [Related]
14. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
15. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study.
Song M; Emilsson L; Bozorg SR; Nguyen LH; Joshi AD; Staller K; Nayor J; Chan AT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):537-547. PubMed ID: 32192628
[TBL] [Abstract][Full Text] [Related]
19. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
Stefanius K; Ylitalo L; Tuomisto A; Kuivila R; Kantola T; Sirniö P; Karttunen TJ; Mäkinen MJ
Histopathology; 2011 Apr; 58(5):679-92. PubMed ID: 21457162
[TBL] [Abstract][Full Text] [Related]
20. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
